Results 121 to 130 of about 6,165 (196)

Macrophage Derived Galectin‐3 Promotes Renal Fibrosis and Diabetic Kidney Disease by Enhancing TGFβ1 Signaling

open access: yesAdvanced Science, Volume 12, Issue 35, September 18, 2025.
Macrophage‐derived Galectin‐3 amplifies TGFβ1 signaling to drive diabetic kidney fibrosis: a novel therapeutic target. Abstract Over 30% of patients with type 2 diabetes develop diabetic kidney disease (DKD), which has emerged as a major contributor to end stage renal disease.
Yibing Chen   +17 more
wiley   +1 more source

Podocalyxin promotes vascular barrier function

open access: yes, 2019
The CD34-family sialomucin, podocalyxin (Podxl), is broadly expressed on the luminal face of blood vessels in adult mammals; however, its biological function on vascular endothelial cells (vEC) is not well-defined. Here, we reveal specific functions for podocalyxin in maintaining endothelial barriers using HUVEC monolayers as a model in vitro. Detailed
openaire   +1 more source

DNA methylation map in circulating leukocytes mirrors subcutaneous adipose tissue methylation pattern: a genome-wide analysis from non-obese and obese patients [PDF]

open access: yes, 2018
The characterization of the epigenetic changes within the obesity-related adipose tissue will provide new insights to understand this metabolic disorder, but adipose tissue is not easy to sample in population-based studies.
Carreira, M. C.   +11 more
core   +1 more source

The MAL protein is crucial for proper membrane condensation at the ciliary base, which is required for primary cilium elongation [PDF]

open access: yes, 2015
The base of the primary cilium contains a zone of condensed membranes whose importance is not known. Here, we have studied the involvement of MAL, a tetraspanning protein that exclusively partitions into condensed membrane fractions, in the condensation ...
Alonso, M.A.   +9 more
core   +2 more sources

Multi‐omics profiling identified two epithelioid sarcoma molecular subtypes with distinct signaling and immune characteristics

open access: yes
Cancer Communications, Volume 45, Issue 12, Page 1760-1766, December 2025.
Carine Ngo   +30 more
wiley   +1 more source

Podocalyxin in the Diagnosis and Treatment of Cancer

open access: yes, 2012
Kelly M. McNagny, Michael R. Hughes, Marcia L. Graves, Erin J. DeBruin, Kimberly Snyder, Jane Cipollone, Michelle Turvey, Poh C.
McNagny, K.   +9 more
openaire   +4 more sources

Joyeux anniversaire, CD34 ! [PDF]

open access: yes, 2005
Vingt ans après la première description de l’antigène CD34, cette molécule continue de susciter la curiosité des scientifiques, qui cherchent toujours à élucider la fonction exacte de ce qui est rapidement apparu comme un « marqueur de la cellule souche ...
Chabannon, Christian
core   +1 more source

Application of miR-193a/WT1/PODXL axis to estimate risk and prognosis of idiopathic membranous nephropathy

open access: yesRenal Failure, 2019
Background: This investigation was managed to explore whether miR-193a in combination with two podocytes, namely, Wilms tumor type 1 (WT1) and podocalyxin (PODXL), were feasible in estimating onset and prognosis of idiopathic membranous nephropathy (IMN).
Wei Zhang, Yeping Ren, Jie Li
doaj   +1 more source

GIV/Girdin is a central hub for profibrogenic signalling networks during liver fibrosis. [PDF]

open access: yes, 2014
Progressive liver fibrosis is characterized by the deposition of collagen by activated hepatic stellate cells (HSCs). Activation of HSCs is a multiple receptor-driven process in which profibrotic signals are enhanced and antifibrotic pathways are ...
Aroonsakool, Nakon   +13 more
core   +1 more source

Erk5 is a mediator to TGFβ1-induced loss of phenotype and function in human podocytes. [PDF]

open access: yes, 2014
Background: Podocytes are highly specialized cells integral to the normal functioning kidney, however, in diabetic nephropathy injury occurs leading to a compromised phenotype and podocyte dysfunction which critically produces podocyte loss with ...
Binder   +39 more
core   +2 more sources

Home - About - Disclaimer - Privacy